🇺🇸 FDA
Patent

US 6943191

Disubstituted lavendustin A analogs and pharmaceutical composition comprising the analogs

expired A61PA61P35/00

Quick answer

US patent 6943191 (Disubstituted lavendustin A analogs and pharmaceutical composition comprising the analogs) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P35/00